No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50040 |
Namalwa |
human |
lymphoblastoid |
This cell line produce interferon. |
|
2 | general cells |
IFO50076 |
IT-45R1 |
rat |
thymus |
T cell differentiation factor producing, (Wistar rat) |
|
3 | general cells |
IFO50090 |
4G12 hybridoma |
mouse x human |
|
This cell line produces human monoclonal 4G12 antibody (Ig lambda). The 4G12 antibody recognizes a glycoprotein with Mr = 65,000. Immunohistochemically, 4G12 reacts especially with lung carcinomas and with some malignant tumors. |
|
4 | general cells |
IFO50098 |
F2408-No.3 |
rat |
embryonic fibroblast |
HGPRT-deficient line from F2408 (IFO 50015). |
|
5 | general cells |
IFO50221 |
N18-RE-105 |
mouse x rat |
|
Neuron like cells established from mouse N18TG2 x Fischer rat 18 day-embryonic neural retina. |
|
6 | general cells |
IFO50285 |
U-251 MG (KO) |
human |
brain |
Subline of U-251 MG (IFO 50288) with epithelial morphology. |
|
7 | general cells |
IFO50310 |
SKG-IIIa |
human |
uterine cervix |
cervical epidermoid carcinoma, clear cell type |
|
8 | general cells |
IFO50357 |
KNS-60 |
human |
brain |
glioma, GFAP, S-100 and NSE-negative |
|
9 | general cells |
IFO50361 |
B2-17 |
human |
brain |
astrocytoma, thymidine kinase-deficient mutant of U-251 MG cells |
|
10 | general cells |
IFO50436 |
KS-1 |
human |
brain |
glioblastoma |
|
11 | general cells |
IFO50481 |
NRK-49F |
rat |
kidney |
NRK-49F is a fibroblastic clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)). This cell line exhibits contact inhibition and is useful for transformation assays. |
|
12 | general cells |
IFO50484 |
DBC1.2 |
mouse |
nasal septum |
This cell line is likely to be derived from olfactory dark (horizontal) basal cell. Keratin is expressed in this cell line. |
|
13 | general cells |
IFO50490 |
MDM2-RNB |
rat |
brain |
human MDM2 protein-expressing astrocyte cell line, (Wistar rat) |
|
14 | general cells |
IFO50491 |
RNB |
rat |
brain |
RNB cells are the parent cells of MDM2-RNB cells (IFO 50490). |
|
15 | general cells |
IFO50495 |
Neuro-2aTG |
mouse |
region of spinal cord |
This cell line is HPRT-deficient clone from EMS-mutagnenized Neuro-2a cells. HAT-sensitive, 6-thioguanine-registant. |
|
16 | general cells |
IFO50525 |
NCO2 |
human |
blood |
Human myelogenous leukemia cell line. |
|
17 | general cells |
JCRB0006 |
HL60RG |
human |
peripheral blood |
Subline of the HL60 having faster growth rate but the capabilities of the differentiation by TPA or etc were declined. |
|
18 | general cells |
JCRB0055 |
LU65B |
human |
lung |
giant cell carcinoma |
|
19 | general cells |
JCRB0056 |
LU65C |
human |
lung |
giant cell carcinoma |
|
20 | general cells |
JCRB0070 |
MIA PaCa-2 |
human |
pancreas |
pancreatic cancer |
|
21 | general cells |
JCRB0078 |
P-815 |
mouse |
tumor |
mastocytoma, (DBA/2 mouse) |
|
22 | general cells |
JCRB0108 |
SCCH-196 |
human |
|
Human small round cell sarcoma. |
|
23 | general cells |
JCRB0113 |
PAI |
mouse |
|
myeloma, (BALB/c mouse) |
|
24 | general cells |
JCRB0120 |
YG10007 |
hamster, Chinese |
lung |
human monomorphic N-acetyltransferase gene introduced CHL cells |
|
25 | general cells |
JCRB0141 |
PHK16-0b |
human |
foreskin |
Normal keratinocyte cells immortalized with HPV16 virus genome and the growth is dependent to EGF. More than 95% of cells are diploid. |
|
26 | general cells |
JCRB0159 |
SLVL |
human |
peripheral blood |
Human villous lymphoma B-cell line from splenic B-cell lymphoma. |
|
27 | general cells |
JCRB0232 |
SKG-IIIa |
human |
cervix |
cervical epidermoid carcinoma, clear cell type |
|
28 | general cells |
JCRB0234.0 |
TYK-nu |
human |
ovary |
undifferentiated carcinoma |
|
29 | general cells |
JCRB0236 |
KG-1-C |
human |
brain |
mixed glioma, GFAP-negative, S-100-positive (growth is very slow). |
|
30 | general cells |
JCRB0252 |
MKN1 |
human |
stomach |
adenosquamous carcinoma |
|
31 | general cells |
JCRB0502 |
TIG-1-30 |
human |
fetus lung |
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 30 |
|
32 | general cells |
JCRB0525 |
TIG-2M-30 |
human |
muscle |
muscular tissue derived normal diploid fibroblast (not myoblast), PDL=about 30 |
|
33 | general cells |
JCRB0612 |
GOTO |
human |
adrenal gland |
neuroblastoma, adrenal gland |
|
34 | general cells |
JCRB0613 |
ITO-II |
human |
testis |
Human testicular tumor cell line. |
|
35 | general cells |
JCRB0626 |
TG1 |
hamster, Chinese |
lung |
V79 derivative, 6-thioguanine-resistant |
|
36 | general cells |
JCRB0706 |
tsFT101 |
mouse |
hybridoma |
FM3A derivative, cytokinesis is blocked at 39 C, (C3H mouse) |
|
37 | general cells |
JCRB0709 |
L5178Y |
mouse |
lymph node |
lymphoma, methylcholanthrene induced, (DBA/2 mouse) |
|
38 | general cells |
JCRB0720 |
OTT6050 |
mouse |
embryo |
teratocarcinoma, (129/Sv mouse) |
|
39 | general cells |
JCRB0738 |
E1A-3Y1-1 |
rat |
embryo/fetus whole |
3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat) |
|
40 | general cells |
JCRB0821 |
NUGC-2 |
human |
stomach |
adenocarcinoma, poorly differentiated |
|
41 | general cells |
JCRB1006.7 |
OUMS-36T-7 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
42 | general cells |
JCRB1018 |
HMY-1 |
human |
skin |
Mlignant melanoma cell line. |
|
43 | general cells |
JCRB1119 |
KUSA-A1 |
mouse |
Bone marrow |
Mouse osteoblastic cell line. |
|
44 | general cells |
JCRB1143 |
UBE6T-7 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
45 | general cells |
JCRB1182 |
NCC-RbC-51 |
human |
cervical lymph node metastasis |
Human retinoblastoma cell line. The growth is very slow. |
|
46 | general cells |
JCRB1185 |
KMS-21BM |
human |
bone marrow |
human myeloma cell line. |
|
47 | general cells |
JCRB1192 |
KMS-28BM |
human |
bone marrow |
human myeloma cell line. |
|
48 | general cells |
JCRB1223 |
NCC-RbC-T1 |
human |
Metastasis in cerebrospinal fluid |
Human retinoblastoma cell line. The growth is very slow. |
|
49 | general cells |
JCRB1358.02 |
SRBC-P18-3-8 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
50 | general cells |
JCRB1358.08 |
SRBC-F31-19-1 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
51 | general cells |
JCRB1358.10 |
SRBC-RP8-18-15 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
52 | general cells |
JCRB1395 |
Kasumi-2 |
human |
blood |
B cell precursor leukemia |
|
53 | general cells |
JCRB1405 |
Minami-2 |
human |
lymphonode |
B cell lymphoma (Burkitt type) |
|
54 | general cells |
JCRB1441 |
ASF-4-4L1 |
human |
skin |
Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
|
55 | general cells |
JCRB1574 |
RSV-M |
mouse |
brain |
Mouse cell line derived from mouse brain tumor. |
|
56 | general cells |
JCRB1636 |
pREP4 c/CHO-S #5/sf |
hamster, Chinese |
ovary |
pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS). |
|
57 | general cells |
JCRB1729 |
RMG-V |
human |
ovary |
Human ovarian clear cell adenocarcinoma cell line. |
|
58 | general cells |
JCRB1795 |
BALM-16 |
human |
peripheral blood |
B cell leukemia cell line, Ig negative, ALL-L3 cell line, t(8;22)(q24;q11), hypercalcemia, mRNA expression of PTHrP |
|
59 | general cells |
JCRB1813 |
BALM-22 |
human |
bone marrow |
B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
|
60 | general cells |
JCRB1828 |
NALM-25 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line.
Derived from the same patient as NALM-24 |
|
61 | general cells |
JCRB1941 |
TU-KatoIII |
human |
Pleural effusion |
Cell line isolated as 100% tumor-forming cells after tumor formation in immunodeficient mice (NOD Scid→Scid→nu/nu). |
|
62 | general cells |
JCRB2209 |
CHO(His9) |
human chromosome-introduced |
ovary |
contains human chromosome # 9 (MTA with Tottori Univ. is required.) |
|
63 | general cells |
JCRB2210 |
A9(Bsr10) |
human chromosome-introduced |
skin |
contains human chromosome #10 (MTA with Tottori Univ. is required.) |
|
64 | general cells |
JCRB2212 |
A9(Neo12) |
human chromosome-introduced |
skin |
contains human chromosome #12 (MTA with Tottori Univ. is required.) |
|
65 | general cells |
JCRB4035 |
Daudi- |
human |
bood |
A clone in which EBV was dropped from Daudi+
|
|
66 | general cells |
JCRB4037 |
KMS21R |
human |
bone marrow |
Lenalidomide-resistant human myeloma cell line established by
long-term exposure of KMS21 cells to low concentration lenalidomide for about one year. |
|
67 | general cells |
JCRB9033 |
STK1 |
mouse |
hybridoma |
anti-DNA polymerase alpha, IgG1 |
|
68 | general cells |
JCRB9102 |
Detroit 525 |
human |
skin |
Turner's syndrome, skin |
|
69 | general cells |
JCRB9107 |
P3/NS1/1-Ag4-1(NS-1) |
mouse |
plasmacytoma |
myeloma, plasmacytoma, non-secreting, 8-azaguanine resistant |
|
70 | general cells |
JCRB9125 |
PG-4(S+L-) |
cat |
brain |
brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.